semaglutide weight loss liver transplant recipients might be a key for breaking the vicious cycle of metabolically associated fatty disease spectrum? ACG 2023 Annual Meeting

Other Approaches May Be Preferable For People Who: Have complex medical histories requiring comprehensive in-person evaluation: If you have multiple chronic conditions, take numerous medications that could interact with GLP-1s, have a history of pancreatitis or gallbladder disease, or have medical circumstances that warrant detailed in-person assessment, traditional in-person care with specialists may be more appropriate than telehealth evaluation based on online questionnaires

For some people, a carefully monitored short course can help kickstart weight loss alongside lifestyle changes

2024 Apr 24;19(4):e0300544

References KFF Health Tracking Poll, November 2025: about one in eight US adults (12 percent) currently take a GLP-1 drug, roughly double the 6 percent in KFF's poll eighteen months earlier

Currently, researchers are studying the clinical utility of GLP-1s in mitigating neurological diseases such as Alzheimers, Parkinsons and addiction